BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today at EUROGIN 2013 that the Company has achieved CE/IVD marking of its BD TotalysTM MultiProcessor, an automated instrument that integrates the pre-processing for the BD SurePath™ Liquid-based Pap Test with a molecular aliquot, maintaining sample integrity while improving efficiency in the lab.
Help employers find you! Check out all the jobs and post your resume.
